According to the Apricus Bio news release they expect the FDA to acknowledge the NDA resubmission within 30 days and by the FDA doing this, shorten the FDA decision to the end of March ( vs. end of April ) in my scenario.
So depending on if and when the FDA actually accepts for review the NDA resubmission is where the 6 month time frame would start.